## What type of research has BMC been involved in? Below are stroke studies that BMC participated in recent years. You can click a logo below or a study name in the menu to the left for more information on individual studies. We have included results on studies that have finished patient enrollment and with available published data. [![patient care](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/aruba-study.jpg)](/stroke-and-cerebrovascular-center/services/arteriovenous-malformations-avms/aruba-study) [**ARUBA** - A Randomized Multicenter Clinical Trial of Unruptured Brain AVMs](/stroke-and-cerebrovascular-center/services/arteriovenous-malformations-avms/aruba-study) --- [![patient care](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/atach-II.jpg)](/stroke-and-cerebrovascular-center/research/completed-studies/atach2) [**ATACH2** - Antihypertensive Treatment of Acute Cerebral Hemorrhage](/stroke-and-cerebrovascular-center/research/completed-studies/atach2) --- [![patient care](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/CAA.jpg)](/stroke-and-cerebrovascular-center/research/completed-studies/caa) [**CAA** - A Phase 2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of Ponezumab in Adult Subjects with Probable Cerebral Amyloid Angiopathy](/stroke-and-cerebrovascular-center/research/completed-studies/caa) --- [![patient care](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/CONSCIOUS3_1_.jpg)](/stroke-and-cerebrovascular-center/research/completed-studies/conscious-3) [**CONSCIOUS3** - Randomized Trial of Clazosentan in Patients with Aneurysmal Subarachnoid Hemorrhage Undergoing Endovascular Coiling](/stroke-and-cerebrovascular-center/research/completed-studies/conscious-3) --- [![patient care](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/milestone-DALF.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/completed-studies/dalf-ps-1016-dalfampridine-patients) [**DALF-PS-1016** - Dalfampridine in Patients with Chronic Deficits after Ischemic Stroke](/stroke-and-cerebrovascular-center/research/completed-studies/dalf-ps-1016-dalfampridine-patients) --- [![patient care](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/DIAS4.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/completed-studies/dias4) [**DIAS4** - Desmoteplase in Acute Ischemic Stroke](/stroke-and-cerebrovascular-center/research/completed-studies/dias4) --- [![patient care](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/isis.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/completed-studies/iris) [**IRIS** - Insulin Resistance Intervention after Stroke Trial](/stroke-and-cerebrovascular-center/research/completed-studies/iris) --- [![patient care](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/marinus.png)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/marinus) [**MARINUS** - A double-blind randomized, placebo-controlled study to evaluate the safety, tolerability, efficacy, and pharmacokinetics of intravenous ganaxolone as adjunctive therapy to treat subjects with status epilepticus](/stroke-and-cerebrovascular-center/research/marinus) --- ![maxQ](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/maxq-ai.jpg) [**MaxQ-AI** - Retrospective Collection of Non-Contrast Head CT images for Clinical Evaluation of MaxQ-AI Accipio Family Software](/stroke-and-cerebrovascular-center/research/completed-studies/maxq-ai) --- [![patient care](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/mariss.jpg)](/stroke-and-cerebrovascular-center/research/mariss) [**MaRISS** - Mild and Rapidly Improving Stroke Study](/stroke-and-cerebrovascular-center/research/mariss-mild-and-rapidly-improving-stroke-study) --- [![patient care](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/mr-rescue.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/completed-studies/mr-rescue) [**MR RESCUE** - A Trial of Imaging Selection and Endovascular Treatment for Ischemic Stroke](/stroke-and-cerebrovascular-center/research/completed-studies/mr-rescue) --- [![patient care](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/spotrias-MRWITNESS.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/mr-witness) [**MR WITNESS** - Intravenous Thrombolysis with Alteplase in MRI-selected Patients](/stroke-and-cerebrovascular-center/research/mr-witness-intravenous-thrombolysis-alteplase-mri) --- [![patient care](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/multistem.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/completed-studies/multistem) [**MULTISTEM** - Double-blind, Randomized, Placebo-controlled Phase 2 Safety and Efficacy Trial of MultiStem in Adults with Ischemic Stroke](/stroke-and-cerebrovascular-center/research/completed-studies/multistem) --- [![patient care](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/navigate-esus.png)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/navigate-esus) [**NAVIGATE-ESUS** - Secondary Prevention of Stroke in Patients with a Recent ESUS](/stroke-and-cerebrovascular-center/research/navigate-esus-secondary-prevention-stroke-patients-recent) --- [![patient care](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/point.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/point) [**POINT** - Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke](/stroke-and-cerebrovascular-center/research/point-platelet-oriented-inhibition-new-tia-and-minor) --- [![patient care](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/university-of-calgary.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/completed-studies/predict) [**PREDICT** - Predicting Hematoma Growth and Outcome in Intracerevral Hemorrhage Using Contrast Bolus CT Scan](/stroke-and-cerebrovascular-center/research/completed-studies/predict) --- [![patient care](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/profess.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/completed-studies/profess) [**PROFESS** - Prevention Regimen for Effectively Avoiding Second Strokes](/stroke-and-cerebrovascular-center/research/completed-studies/profess) --- [![patient care](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/status-trial.png)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/sage-547-301) [**SAGE 547-301** - A Phase 3 Randomized Clinical Trial to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus](/stroke-and-cerebrovascular-center/research/sage-547-301) --- [![patient care](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/status-trial.png)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/sage-547-302) [**SAGE 547-302** - To Evaluate Open-Label Use of SAGE-547 (Allopregnanolone) in the Treatment of Subjects with Super-Refractory Status Epilepticus](/stroke-and-cerebrovascular-center/research/sage-547-302) --- [![patient care](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/SOCRATES.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/completed-studies/socrates-acute-stroke-or-transient) [**SOCRATES** - Acute Stroke or Transient Ischemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes](/stroke-and-cerebrovascular-center/research/completed-studies/socrates-acute-stroke-or-transient) --- [![patient care](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/sps3.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/completed-studies/sps3) [**SPS3** - Secondary Prevention of Small Subcortical Strokes](/stroke-and-cerebrovascular-center/research/completed-studies/sps3) --- [![patient care](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/team-trial-on-endovascular.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/completed-studies/team) [**TEAM** - A Trial on Unruptured Intracranial Aneurysms](/stroke-and-cerebrovascular-center/research/completed-studies/team) --- [![patient care](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/tra-2p.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/completed-studies/tra-2p-%E2%80%93-timi-50) [**TRA2P-TIMI50** - Trial to Assess the Effects of SCH530348 in Preventing Heart Attach and Stroke in Patients with Atherosclerosis](/stroke-and-cerebrovascular-center/research/completed-studies/tra-2p-%E2%80%93-timi-50)